By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Feb 24, 2021/News
The spot, to be distributed nationwide, is a call to increase physical activity—and seek PTs and PTAs to help improve and restore movement.
Sep 10, 2019/News
APTA's consumer-focused website adopted a new name—and a new look—to support consumer understanding of physical therapy.
Apr 29, 2019/News
Working across health care disciplines isn't a pipe dream: it's an increasingly important fact of professional life for physical therapists (PTs) and physical therapists assistants (PTAs). And physical therapy education programs are helping future PTs and PTAs respond to this reality by adapting curricula
Jun 29, 2017/News
Days after the Senate introduced a bill that threatens to weaken required essential health benefits, a trio of coalitions sponsored a briefing on Capitol Hill to highlight the value of rehabilitation and habilitation services,
Jul 12, 2021/Test & Measure
The Harris Infant Neuromotor Test (HINT) is a screening tool designed to identify neuromotor or cognitive/behavioral concerns in infants who are healthy or at high risk between the ages of 3 and 12 months.
Nov 24, 2020/Article
The culturally competent practice of physical therapy includes practice with patients and clients who have mental or physical disabilities.
Feb 13, 2025/Roundup
Resources to help guide your patient care are free to members and easy to find at apta.org. Here’s what was new in 2024.
Jun 9, 2025/Article
APTA is actively working with congressional leaders to address reports of remaining TRICARE payment and operational issues impacting physical therapy providers. These issues, which emerged at the start of 2025 when TriWest Healthcare Alliance took over as the Managed Care Support Contractor under the
May 23, 2017/Test & Measure
Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.
Jan 13, 2023/Review
Authors found a dose-response relationship between PA and adverse COVID-19 events that was consistent across multiple subgroups.